Literature DB >> 27869141

Fronto-Striatal Glutamate in Autism Spectrum Disorder and Obsessive Compulsive Disorder.

Jilly Naaijen1, Marcel P Zwiers1, Houshang Amiri1,2, Steven C R Williams3, Sarah Durston4, Bob Oranje4, Daniel Brandeis5,6,7,8, Regina Boecker-Schlier5, Matthias Ruf9, Isabella Wolf5,9, Tobias Banaschewski5, Jeffrey C Glennon1, Barbara Franke10,11, Jan K Buitelaar1,12, David J Lythgoe3.   

Abstract

Autism spectrum disorders (ASDs) and obsessive compulsive disorder (OCD) are often comorbid with the overlap based on compulsive behaviors. Although previous studies suggest glutamatergic deficits in fronto-striatal brain areas in both disorders, this is the first study to directly compare the glutamate concentrations across the two disorders with those in healthy control participants using both categorical and dimensional approaches. In the current multi-center study (four centers), we used proton magnetic resonance spectroscopy in 51 children with ASD, 29 with OCD, and 53 healthy controls (aged 8-13 years) to investigate glutamate (Glu) concentrations in two regions of the fronto-striatal circuit: midline anterior cingulate cortex (ACC) and left dorsal striatum. Spectra were processed with Linear Combination Model. Group comparisons were performed with one-way analyses of variance including sex, medication use, and scanner site as covariates. In addition, a dimensional analysis was performed, linking glutamate with a continuous measure of compulsivity across disorders. There was a main group effect for ACC glutamate (p=0.019). Contrast analyses showed increased glutamate both in children with ASD and OCD compared with controls (p=0.007), but no differences between the two disorders (p=0.770). Dimensional analyses revealed a positive correlation between compulsive behavior (measured with the Repetitive Behavior Scale) and ACC glutamate (rho=0.24, p=0.03). These findings were robust across sites. No differences were found in the striatum. The current findings confirm overlap between ASD and OCD in terms of glutamate involvement. Glutamate concentration in ACC seems to be associated with the severity of compulsive behavior.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27869141      PMCID: PMC5645732          DOI: 10.1038/npp.2016.260

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

Review 1.  The trouble with quality filtering based on relative Cramér-Rao lower bounds.

Authors:  Roland Kreis
Journal:  Magn Reson Med       Date:  2015-03-06       Impact factor: 4.668

2.  Neurochemicals measured by (1)H-MR spectroscopy: putative vulnerability biomarkers for obsessive compulsive disorder.

Authors:  Sundar Gnanavel; Pratap Sharan; Sudhir Khandelwal; Uma Sharma; Naranamangalam R Jagannathan
Journal:  MAGMA       Date:  2013-12-12       Impact factor: 2.310

3.  The Development and Well-Being Assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology.

Authors:  R Goodman; T Ford; H Richards; R Gatward; H Meltzer
Journal:  J Child Psychol Psychiatry       Date:  2000-07       Impact factor: 8.982

Review 4.  Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies.

Authors:  Jilly Naaijen; David J Lythgoe; Houshang Amiri; Jan K Buitelaar; Jeffrey C Glennon
Journal:  Neurosci Biobehav Rev       Date:  2015-02-21       Impact factor: 8.989

5.  Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders.

Authors:  C Lord; M Rutter; A Le Couteur
Journal:  J Autism Dev Disord       Date:  1994-10

6.  The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Authors:  Clifford R Jack; Matt A Bernstein; Nick C Fox; Paul Thompson; Gene Alexander; Danielle Harvey; Bret Borowski; Paula J Britson; Jennifer L Whitwell; Chadwick Ward; Anders M Dale; Joel P Felmlee; Jeffrey L Gunter; Derek L G Hill; Ron Killiany; Norbert Schuff; Sabrina Fox-Bosetti; Chen Lin; Colin Studholme; Charles S DeCarli; Gunnar Krueger; Heidi A Ward; Gregory J Metzger; Katherine T Scott; Richard Mallozzi; Daniel Blezek; Joshua Levy; Josef P Debbins; Adam S Fleisher; Marilyn Albert; Robert Green; George Bartzokis; Gary Glover; John Mugler; Michael W Weiner
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

Review 7.  Developmental neurobiology of cognitive control and motivational systems.

Authors:  Leah H Somerville; B J Casey
Journal:  Curr Opin Neurobiol       Date:  2010-02-16       Impact factor: 6.627

Review 8.  Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry.

Authors:  Trevor W Robbins; Claire M Gillan; Dana G Smith; Sanne de Wit; Karen D Ersche
Journal:  Trends Cogn Sci       Date:  2011-12-10       Impact factor: 20.229

9.  Quality of 186 child brain spectra using motion and B0 shim navigated single voxel spectroscopy.

Authors:  Aaron T Hess; André J W van der Kouwe; Kenneth K Mbugua; Barbara Laughton; Ernesta M Meintjes
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

10.  The Repetitive Behavior Scale-Revised: independent validation in individuals with autism spectrum disorders.

Authors:  Kristen S L Lam; Michael G Aman
Journal:  J Autism Dev Disord       Date:  2007-05
View more
  11 in total

1.  Magnetic Resonance Spectroscopy (MRS) and Positron Emission Tomography (PET) Imaging in Obsessive-Compulsive Disorder.

Authors:  Marjan Biria; Lucia-Manuela Cantonas; Paula Banca
Journal:  Curr Top Behav Neurosci       Date:  2021

2.  Functional histamine H3 and adenosine A2A receptor heteromers in recombinant cells and rat striatum.

Authors:  Ricardo Márquez-Gómez; Meridith T Robins; Citlaly Gutiérrez-Rodelo; Juan-Manuel Arias; Jesús-Alberto Olivares-Reyes; Richard M van Rijn; José-Antonio Arias-Montaño
Journal:  Pharmacol Res       Date:  2017-12-05       Impact factor: 7.658

3.  Motor Cortex Excitation/Inhibition Imbalance in Young Adults With Autism Spectrum Disorder: A MRS-TMS Approach.

Authors:  Inês Bernardino; Ana Dionísio; Inês R Violante; Raquel Monteiro; Miguel Castelo-Branco
Journal:  Front Psychiatry       Date:  2022-04-14       Impact factor: 5.435

4.  Sympathetic, Metabolic Adaptations, and Oxidative Stress in Autism Spectrum Disorders: How Far From Physiology?

Authors:  Antonietta Messina; Vincenzo Monda; Francesco Sessa; Anna Valenzano; Monica Salerno; Ilaria Bitetti; Francesco Precenzano; Rosa Marotta; Francesco Lavano; Serena M Lavano; Margherita Salerno; Agata Maltese; Michele Roccella; Lucia Parisi; Roberta I Ferrentino; Gabriele Tripi; Beatrice Gallai; Giuseppe Cibelli; Marcellino Monda; Giovanni Messina; Marco Carotenuto
Journal:  Front Physiol       Date:  2018-03-22       Impact factor: 4.566

5.  Functional EEG connectivity in infants associates with later restricted and repetitive behaviours in autism; a replication study.

Authors:  Rianne Haartsen; Emily J H Jones; Elena V Orekhova; Tony Charman; Mark H Johnson
Journal:  Transl Psychiatry       Date:  2019-02-04       Impact factor: 6.222

Review 6.  The Neuronal Glutamate Transporter EAAT3 in Obsessive-Compulsive Disorder.

Authors:  Angélica P Escobar; Jens R Wendland; Andrés E Chávez; Pablo R Moya
Journal:  Front Pharmacol       Date:  2019-11-15       Impact factor: 5.810

7.  Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis.

Authors:  Fatemeh Hadi; Shayan Kashefinejad; Leila Kamalzadeh; Saba Hoobehfekr; Mohammadreza Shalbafan
Journal:  BMC Pharmacol Toxicol       Date:  2021-11-04       Impact factor: 2.483

Review 8.  Anorexia Nervosa-What Has Changed in the State of Knowledge about Nutritional Rehabilitation for Patients over the Past 10 Years? A Review of Literature.

Authors:  Katarzyna Jowik; Marta Tyszkiewicz-Nwafor; Agnieszka Słopień
Journal:  Nutrients       Date:  2021-10-27       Impact factor: 5.717

9.  Cortical inhibition in neurofibromatosis type 1 is modulated by lovastatin, as demonstrated by a randomized, triple-blind, placebo-controlled clinical trial.

Authors:  Inês Bernardino; Ana Dionísio; Miguel Castelo-Branco
Journal:  Sci Rep       Date:  2022-08-15       Impact factor: 4.996

10.  Interest in food and triglyceride concentrations in children and adolescents with autistic spectrum disorder.

Authors:  Josiane da Cunha Luçardo; Giliane Fraga Monk; Mariane da Silva Dias; Thais Martins-Silva; Mayra Pacheco Fernandes; Juliana Costa Maia; Sandra Costa Valle; Juliana Dos Santos Vaz
Journal:  J Pediatr (Rio J)       Date:  2020-02-19       Impact factor: 2.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.